인쇄하기
취소

Ildong inked with NBP Pharmaceutical to introduce China's first class new medicine

Published: 2007-12-10 06:56:00
Updated: 2007-12-10 06:56:00
Ildong Pharm has signed an exclusive license agreement with ShiJiaZhuang Pharma Group NBP Pharmaceutical Co. in Peking to distribute in Korea Butylphthalide soft capsule (3-nbutylphthalide; NBP), which is the first Class I new medicine in brain-vessel field of China.

Ildong said NBP is expected to be launched in the latter of 2010 after completion of local clinical trials, which will streng...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.